MITOMYCIN FOR INJECTION, USP
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of MITOMYCIN FOR INJECTION, USP in Canada?
No. There is no current shortage of MITOMYCIN FOR INJECTION, USP 20MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MUTAMYCIN INJ 20MG/VIAL
BRISTOL-MYERS SQUIBB CANADA
Other Products
MUTAMYCIN INJ 5MG/VIAL
BRISTOL-MYERS SQUIBB CANADA
MITOMYCIN FOR INJECTION USP
PFIZER CANADA ULC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02531941
Strength
20MG
Dosage Form
Powder For Solution
Route
Intravesical Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.4MG · DIN 02432188
0.6MG · DIN 02432196
100MG · DIN 02507668
0.05MG · DIN 02457059
2MG · DIN 02457075
0.2% · DIN 02515377
1G · DIN 02437112
500MG · DIN 02437104
10G · DIN 02437120
2G · DIN 02499096